Quick Picks - Watson Pharmaceuticals (NYSE:WPI) announced today that the FDA has approved the company’s generic version of Lidoderm, a skin patch that delivers the painkiller lidocaine currently … Continue Reading
Read NowQuick Picks - Oncothyreon (NASDAQ:ONTY) is up 11% this morning after a major gap from yesterday’s close took shares to $4.94. The jump comes on the heels of … Continue Reading
Read NowQuick Picks - Bristol-Myer’s Squibb (NYSE:BMY) announced last night that it would be officially discontinuing development of its Hepatitis C treatment, known as BMS-986094, and revealed the financial … Continue Reading
Read NowLong Ideas - Spectrum Pharmaceuticals (NASDAQ:SPPI) is defending its Fusilev cancer treatment franchise after a recent article suggested that pricing for the drug had been cut. An article … Continue Reading
Read NowLong Ideas - Australian-listed Prana Biotechnology (ASX:PBT)(NASDAQ:PRAN) gave updates today on the company’s ongoing Phase II trials for lead compound PBT2, a potential treatment for neurodegenerative diseases Alzheimer’s … Continue Reading
Read NowLong Ideas - Shares of PROLOR Biotech (NYSEAMEX:PBTH) are trading up this morning after Jefferies initiated a “Buy” rating with an $8 price target. The company develops a … Continue Reading
Read NowQuick Picks - Shares of Amarin Corp. (NASDAQ:AMRN) are up about 2% this morning against a weak tape, as Jeffries analyst Thomas Wei commented that the delay in … Continue Reading
Read Now